Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy

Neurosurgery. 2017 Nov 1;81(5):N34-N36. doi: 10.1093/neuros/nyx453.
No abstract available